At ESAD 2025, researchers reported that Viperin (RSAD2) is strongly induced by inflammatory cytokines in pancreatic beta cells and islets.

Medically reviewed by Violetta Shamilova, PharmD Key Takeaways Poor sleep can not only make you feel lousy, but it can also lead to chronic conditions. Implementing healthy habits and relaxation ...

Discover investment opportunities in Rezolute, Inc. as new drug ersodetug advances in phase 3 HI trials, with catalysts ...

Alzheimer’s disease has proved to be a tricky target, and researchers and drug developers have been pursuing effective ...

On 03 September 2025, Hoffmann-La Roche conducted a study is to assess the long-term safety and to explore the efficacy of ...

The open-angle glaucoma market is projected to grow steadily, driven by the rising global prevalence of glaucoma due to aging populations and increasing awareness of early diagnosis. Additionally, the ...

Long-term benzodiazepine use in older adults disrupts sleep patterns, leading to lighter sleep and potential cognitive ...

Bicara Therapeutics Inc.’s ficera shows strong results in HPV-negative HNSCC trials. But is BCAX stock worth buying now?

The new Prescription Drug User Fee Act target date is now December 7, 2025. The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for ...

Alpha-Beta Consulting has denounced claims contained in a report by online newspaper as misleading and un-founding. The firm, in a statement by Head of Human Capital Management Mrs. Anjolaoluwa Ige, ...

Many medications can help lower high blood pressure (hypertension), but no single one works best for everyone. The good news is, with some patience and help from your healthcare provider, you’ll ...